Table 6.
Progress indicators for PET/MRI in oncology, including paediatric imaging
| 2012 | 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|---|
| Definition of key clinical applications | ↔ | ↔ | ↗ | ↗ | ↗ |
| Diagnostic quality of PET in PET/MRI equivalent to PET quality in PET/CT | ↔ | ↔ | ↗ | ↗ | ↗ |
| Resolving quantitative bias from MR-AC | ↘ | ↔ | ↔ | ↔ | ↗ |
| Clinical data available on diagnostic accuracy of PET(/MRI) in oncology | ↔ | ↔ | ↗ | ↔ | ↗ |
| PET/MRI protocol standardisation | ↓ | ↔ | ↘ | ↔ | ↔ |
| Clinical evidence on the usefulness of PET/MRI in paediatric oncology | ↔ | ↗ | ↗ | ↗ | ↔ |
| Reduced radiation exposure as a key driver for PET/MRI of children | ↗ | ↑ | ↑ | ↔ | ↘ |
| Initial results of a complementary role of advanced MRI techniques for restaging of lymphoma patients | ↔ | ↔ | ↗ | ↔ | ↔ |